Evidence map›Paper›PMID 41593793›Full record

ArticleBMC pharmacology & toxicology2026

Decrypting potential mechanisms linking ochratoxin A to hepatocellular carcinoma: an integrated approach combining toxicology, machine learning, molecular docking, and molecular dynamics simulation.

Junyi Zhuo, Hua Wu, Xiaoling Zhou, Xi Wang, Tianqi Qiu, Min Lin, Yu Tang

Abstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junyi ZhuoDepartment of Gastroenterology, The People's Hospital of Leshan, Southwest Medical University, No. 639 Huian Road, Leshan, Sichuan, 614000, China.
Hua WuDepartment of Pediatrics, The People's Hospital of Leshan, Southwest Medical University, Leshan, Sichuan, China.
Xiaoling ZhouHealth Care Center, The People's Hospital of Leshan, Southwest Medical University, Leshan, Sichuan, China.
Xi WangHealth Care Center, The People's Hospital of Leshan, Southwest Medical University, Leshan, Sichuan, China.
Tianqi QiuDepartment of Gastroenterology, The People's Hospital of Leshan, Southwest Medical University, No. 639 Huian Road, Leshan, Sichuan, 614000, China.
Min LinDepartment of Gastroenterology, The People's Hospital of Leshan, Southwest Medical University, No. 639 Huian Road, Leshan, Sichuan, 614000, China.
Yu TangDepartment of Gastroenterology, The People's Hospital of Leshan, Southwest Medical University, No. 639 Huian Road, Leshan, Sichuan, 614000, China. tangyuchinatown@163.com.

Funding

Municipal Key Science and Technology Program of Leshan No. 24ZDYF0098Sichuan Association of the Integration of Traditional Chinese and Western Medicine No. ZXY2025010Sichuan Medical Science and Technology Innovation Research Association YCH-KY-YCZD2024-135
6 · The paper itself

Abstract

backgroundOchratoxin A (OTA), a common food-borne mycotoxin, is a potential human carcinogen, yet the specific molecular mechanisms linking it to hepatocellular carcinoma (HCC) remain unclear.

methodsWe integrated network toxicology to predict OTA targets and intersected them with HCC transcriptomic data to identify key candidate genes. Functional enrichment analysis was then conducted. Multiple machine learning algorithms were applied to screen and validate core genes. Furthermore, molecular docking and molecular dynamics (MD) simulations were employed to evaluate the binding stability between OTA and key target proteins.

resultsA total of 50 key genes were identified as potential targets for potential OTA-associated hepatocarcinogenesis. Enrichment analysis revealed their significant involvement in critical processes such as xenobiotic metabolism and oxidative stress response. Machine learning analysis prioritized eight core genes (AURKA, GABARAPL1, CA2, PARP1, LMNA, SLC27A5, EPHX2, and GSTP1), and a combined diagnostic model demonstrated outstanding performance (AUC = 0.986). Structural analyses via molecular docking and MD simulations confirmed stable binding interactions between OTA and these core targets.

conclusionsThis integrated computational study identifies a set of candidate genes through which OTA may potentially interact with HCC-associated molecular networks. The robust binding predicted between OTA and the core targets provides a structural basis for these interactions. These findings offer a prioritized list of targets and a theoretical framework for subsequent experimental validation and investigation into OTA's toxicological role in HCC.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsOchratoxinsHumansMachine LearningMolecular Docking SimulationMolecular Dynamics Simulationochratoxin AOchratoxinsBioinformaticsHepatocellular carcinomaMachine learningMolecular dockingMolecular dynamics simulationOchratoxin A

Identifiers

PMID41593793
PMCPMC12924422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.